Company	Price	Valuation					Profitability					Cash & leverage					Quality				Rating
		P/E	P/B	P/S	EV / EBITDA	DCF upside	Gross margin	Operating margin	Net margin	ROE	ROIC	FCF yield	Debt / equity	Net debt / EBITDA	Interest coverage	Current ratio	Dividend yield	Piotroski (0-9)	Altman Z	Rating score (1-5)
IRWDthis companyIronwood Pharmaceuticals, Inc.	$4.46	22.47×	-2.09×	1.85×	8.88×	79.1%	100.0%	40.1%	8.1%	-9.2%	11.4%	23.2%	-2.28×	3.65×	3.63×	1.13×	0.0%	7	-2.15	3	B
ARDXArdelyx, Inc.	$2.96	-22.42×	8.42×	3.45×	-53.09×	-5941.7%	89.5%	-10.1%	-15.1%	-36.9%	-9.9%	-3.1%	1.27×	-4.92×	-1.44×	4.31×	0.0%	2	-0.11	1	D+
SYRESpyre Therapeutics, Inc.	$108.42	-16.55×	2.93×	0×	-9.6×	-98.7%	0.0%	0.0%	0.0%	-21.7%	-29.1%	-8.1%	0×	0.41×	0×	13.25×	0.0%	2	73.63	1	D+
Peer median	—	-19.48×	5.68×	1.72×	-31.35×	-3020.2%	44.8%	-5.0%	-7.6%	-29.3%	-19.5%	-5.6%	0.63×	-2.26×	-0.72×	8.78×	0.0%	2	36.76	1	—